HEADER VIRAL PROTEIN 23-SEP-20 7D4G TITLE A PROOF OF CONCEPT FOR NEUTRALIZING ANTIBODY-GUIDED VACCINE DESIGN TITLE 2 AGAINST SARS-COV-2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SPIKE GLYCOPROTEIN S1; COMPND 3 CHAIN: B; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: LIGHT CHAIN OF FC05 FAB; COMPND 7 CHAIN: G; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: HEAVY CHAIN OF FC05 FAB; COMPND 11 CHAIN: N; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_COMMON: 2019-NCOV; SOURCE 5 ORGANISM_TAXID: 2697049; SOURCE 6 GENE: S, 2; SOURCE 7 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 14 EXPRESSION_SYSTEM_CELL_LINE: HEK293T; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 17 ORGANISM_TAXID: 9606; SOURCE 18 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 19 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 20 EXPRESSION_SYSTEM_CELL_LINE: HEK293T KEYWDS SARS-COV-2, SPIKE, ANTIBODY, VIRAL PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR L.CAO,X.WANG REVDAT 2 23-FEB-22 7D4G 1 JRNL REVDAT 1 07-APR-21 7D4G 0 JRNL AUTH L.ZHANG,L.CAO,X.S.GAO,B.Y.ZHENG,Y.Q.DENG,J.X.LI,R.FENG, JRNL AUTH 2 Q.BIAN,X.L.GUO,N.WANG,H.Y.QIU,L.WANG,Z.CUI,Q.YE,G.CHEN, JRNL AUTH 3 K.K.LU,Y.CHEN,Y.T.CHEN,H.X.PAN,J.YU,W.YAO,B.L.ZHU,J.CHEN, JRNL AUTH 4 Y.LIU,C.F.QIN,X.WANG,F.C.ZHU JRNL TITL A PROOF OF CONCEPT FOR NEUTRALIZING ANTIBODY-GUIDED VACCINE JRNL TITL 2 DESIGN AGAINST SARS-COV-2. JRNL REF NATL SCI REV V. 8 AB053 2021 JRNL REFN ESSN 2053-714X JRNL PMID 34676098 JRNL DOI 10.1093/NSR/NWAB053 REMARK 2 REMARK 2 RESOLUTION. 3.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.900 REMARK 3 NUMBER OF PARTICLES : 450378 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7D4G COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 24-SEP-20. REMARK 100 THE DEPOSITION ID IS D_1300018725. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : FC05 FAB BINDS TO SARS-COV-2 REMARK 245 SPIKE; SPIKE PROTEIN S1; FC05 REMARK 245 FAB REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 8.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K2 QUANTUM (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, G, N REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER B 13 REMARK 465 GLY B 252 REMARK 465 ASP B 253 REMARK 465 SER B 254 REMARK 465 SER B 255 REMARK 465 GLN G 1 REMARK 465 SER N 121 REMARK 465 SER N 122 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER B 45 OG REMARK 470 GLU B 154 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLU N 32 CG PRO N 102 1.92 REMARK 500 O ASP N 91 OH TYR N 95 2.12 REMARK 500 O GLU N 32 CB PRO N 102 2.12 REMARK 500 NH1 ARG B 273 OD2 ASP B 290 2.13 REMARK 500 CB PRO N 54 CB SER N 104 2.13 REMARK 500 CG2 VAL B 42 NH1 ARG B 44 2.16 REMARK 500 O ARG G 62 OG1 THR G 77 2.16 REMARK 500 CB PRO N 54 OG SER N 104 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR B 20 -138.13 64.65 REMARK 500 ARG B 21 -64.53 -133.96 REMARK 500 LEU B 24 155.84 75.21 REMARK 500 PHE B 32 -72.51 -81.32 REMARK 500 ALA B 67 -158.67 -78.51 REMARK 500 THR B 73 -67.55 -131.37 REMARK 500 THR B 76 69.78 60.97 REMARK 500 ASN B 87 -136.17 57.46 REMARK 500 THR B 95 -75.22 -106.77 REMARK 500 ARG B 102 -59.90 -127.09 REMARK 500 THR B 108 -66.69 -122.38 REMARK 500 ASP B 111 -169.88 -161.92 REMARK 500 LYS B 113 -15.43 78.70 REMARK 500 ASN B 121 61.34 -162.88 REMARK 500 LYS B 147 -10.30 60.75 REMARK 500 ASN B 149 -10.26 73.87 REMARK 500 ASN B 165 -0.09 64.52 REMARK 500 LEU B 179 -62.34 -135.64 REMARK 500 GLU B 180 -147.56 57.57 REMARK 500 ASN B 185 -13.52 67.71 REMARK 500 LYS B 187 -10.00 71.77 REMARK 500 ARG B 214 -69.58 -132.67 REMARK 500 LEU B 226 -72.58 -84.15 REMARK 500 ILE B 231 -73.79 -88.35 REMARK 500 THR B 259 71.93 65.25 REMARK 500 GLN B 271 139.12 -178.04 REMARK 500 THR B 286 -72.10 -127.75 REMARK 500 ASN G 28 -67.39 -127.18 REMARK 500 LEU G 48 -66.63 -94.13 REMARK 500 ASP G 51 17.61 58.41 REMARK 500 ASN G 52 -20.50 64.18 REMARK 500 SER N 8 -56.47 -131.56 REMARK 500 PRO N 31 42.23 -90.53 REMARK 500 ASP N 56 -12.32 66.58 REMARK 500 SER N 104 -169.75 80.62 REMARK 500 ASP N 110 175.21 69.23 REMARK 500 GLN N 114 -16.52 74.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ALA B 123 THR B 124 149.99 REMARK 500 TYR B 248 LEU B 249 -141.81 REMARK 500 SER N 8 GLY N 9 -144.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-30573 RELATED DB: EMDB REMARK 900 A PROOF OF CONCEPT FOR NEUTRALIZING ANTIBODY-GUIDED VACCINE DESIGN REMARK 900 AGAINST SARS-COV-2 DBREF 7D4G B 13 290 UNP P0DTC2 SPIKE_SARS2 13 290 DBREF 7D4G G 1 110 PDB 7D4G 7D4G 1 110 DBREF 7D4G N 1 122 PDB 7D4G 7D4G 1 122 SEQRES 1 B 278 SER GLN CYS VAL ASN LEU THR THR ARG THR GLN LEU PRO SEQRES 2 B 278 PRO ALA TYR THR ASN SER PHE THR ARG GLY VAL TYR TYR SEQRES 3 B 278 PRO ASP LYS VAL PHE ARG SER SER VAL LEU HIS SER THR SEQRES 4 B 278 GLN ASP LEU PHE LEU PRO PHE PHE SER ASN VAL THR TRP SEQRES 5 B 278 PHE HIS ALA ILE HIS VAL SER GLY THR ASN GLY THR LYS SEQRES 6 B 278 ARG PHE ASP ASN PRO VAL LEU PRO PHE ASN ASP GLY VAL SEQRES 7 B 278 TYR PHE ALA SER THR GLU LYS SER ASN ILE ILE ARG GLY SEQRES 8 B 278 TRP ILE PHE GLY THR THR LEU ASP SER LYS THR GLN SER SEQRES 9 B 278 LEU LEU ILE VAL ASN ASN ALA THR ASN VAL VAL ILE LYS SEQRES 10 B 278 VAL CYS GLU PHE GLN PHE CYS ASN ASP PRO PHE LEU GLY SEQRES 11 B 278 VAL TYR TYR HIS LYS ASN ASN LYS SER TRP MET GLU SER SEQRES 12 B 278 GLU PHE ARG VAL TYR SER SER ALA ASN ASN CYS THR PHE SEQRES 13 B 278 GLU TYR VAL SER GLN PRO PHE LEU MET ASP LEU GLU GLY SEQRES 14 B 278 LYS GLN GLY ASN PHE LYS ASN LEU ARG GLU PHE VAL PHE SEQRES 15 B 278 LYS ASN ILE ASP GLY TYR PHE LYS ILE TYR SER LYS HIS SEQRES 16 B 278 THR PRO ILE ASN LEU VAL ARG ASP LEU PRO GLN GLY PHE SEQRES 17 B 278 SER ALA LEU GLU PRO LEU VAL ASP LEU PRO ILE GLY ILE SEQRES 18 B 278 ASN ILE THR ARG PHE GLN THR LEU LEU ALA LEU HIS ARG SEQRES 19 B 278 SER TYR LEU THR PRO GLY ASP SER SER SER GLY TRP THR SEQRES 20 B 278 ALA GLY ALA ALA ALA TYR TYR VAL GLY TYR LEU GLN PRO SEQRES 21 B 278 ARG THR PHE LEU LEU LYS TYR ASN GLU ASN GLY THR ILE SEQRES 22 B 278 THR ASP ALA VAL ASP SEQRES 1 G 110 GLN SER VAL LEU THR GLN ALA PRO SER VAL SER GLY ALA SEQRES 2 G 110 PRO GLY GLN LYS VAL THR ILE SER CYS SER GLY SER SER SEQRES 3 G 110 SER ASN ILE GLY ASN ASN TYR VAL SER TRP TYR GLN GLN SEQRES 4 G 110 LEU PRO GLY THR ALA PRO LYS LEU LEU ILE TYR ASP ASN SEQRES 5 G 110 ASN LYS ARG PRO SER GLY ILE PRO ASP ARG PHE SER GLY SEQRES 6 G 110 SER LYS SER GLY THR SER ALA THR LEU GLY ILE THR GLY SEQRES 7 G 110 LEU GLN THR GLY ASP GLU ALA ASP TYR TYR CYS GLY THR SEQRES 8 G 110 TRP ASP SER SER LEU SER ALA VAL VAL PHE GLY GLY GLY SEQRES 9 G 110 THR LYS LEU THR VAL LEU SEQRES 1 N 122 GLU VAL GLN LEU LEU GLU GLN SER GLY ALA GLU VAL LYS SEQRES 2 N 122 LYS PRO GLY ALA SER VAL ARG VAL SER CYS LYS VAL SER SEQRES 3 N 122 GLY TYR THR LEU PRO GLU VAL ALA MET HIS TRP VAL ARG SEQRES 4 N 122 GLN ALA PRO GLY LYS GLY LEU GLU TRP MET GLY GLY PHE SEQRES 5 N 122 ASP PRO GLU ASP GLY GLU THR MET TYR ALA GLN LYS PHE SEQRES 6 N 122 GLN GLY ARG VAL THR MET THR GLU ASP THR SER THR ASP SEQRES 7 N 122 THR ALA TYR MET GLU LEU SER SER LEU ARG SER GLU ASP SEQRES 8 N 122 THR ALA VAL TYR TYR CYS ALA THR THR THR PRO PHE SER SEQRES 9 N 122 SER SER TYR TRP PHE ASP PRO TRP GLY GLN GLY THR LEU SEQRES 10 N 122 VAL THR VAL SER SER HELIX 1 AA1 GLU B 156 ARG B 158 5 3 HELIX 2 AA2 GLN G 80 GLU G 84 5 5 HELIX 3 AA3 THR N 29 VAL N 33 5 5 SHEET 1 AA1 7 TYR B 28 SER B 31 0 SHEET 2 AA1 7 SER B 60 HIS B 66 -1 O VAL B 62 N THR B 29 SHEET 3 AA1 7 ALA B 264 TYR B 269 -1 O TYR B 265 N PHE B 65 SHEET 4 AA1 7 VAL B 90 SER B 94 -1 N ALA B 93 O TYR B 266 SHEET 5 AA1 7 LEU B 189 ILE B 197 -1 O ARG B 190 N SER B 94 SHEET 6 AA1 7 TYR B 200 THR B 208 -1 O TYR B 200 N ILE B 197 SHEET 7 AA1 7 GLU B 224 PRO B 230 -1 O LEU B 226 N ILE B 203 SHEET 1 AA2 3 LEU B 48 PHE B 55 0 SHEET 2 AA2 3 GLN B 271 LYS B 278 -1 O LEU B 277 N HIS B 49 SHEET 3 AA2 3 ASP B 287 VAL B 289 -1 O ASP B 287 N LYS B 278 SHEET 1 AA3 2 LEU B 84 PRO B 85 0 SHEET 2 AA3 2 ARG B 237 PHE B 238 -1 O PHE B 238 N LEU B 84 SHEET 1 AA4 4 ILE B 101 TRP B 104 0 SHEET 2 AA4 4 THR B 240 LEU B 244 -1 O LEU B 241 N GLY B 103 SHEET 3 AA4 4 LEU B 141 TYR B 145 1 N LEU B 141 O LEU B 242 SHEET 4 AA4 4 TRP B 152 SER B 155 -1 O SER B 155 N GLY B 142 SHEET 1 AA5 3 SER B 116 VAL B 120 0 SHEET 2 AA5 3 VAL B 126 PHE B 135 -1 O LYS B 129 N LEU B 118 SHEET 3 AA5 3 TYR B 160 SER B 172 -1 O PHE B 168 N VAL B 130 SHEET 1 AA6 5 SER G 9 GLY G 12 0 SHEET 2 AA6 5 THR G 105 VAL G 109 1 O THR G 108 N GLY G 12 SHEET 3 AA6 5 ASP G 86 ASP G 93 -1 N TYR G 87 O THR G 105 SHEET 4 AA6 5 VAL G 34 GLN G 39 -1 N SER G 35 O GLY G 90 SHEET 5 AA6 5 LYS G 46 TYR G 50 -1 O LYS G 46 N GLN G 38 SHEET 1 AA7 4 SER G 9 GLY G 12 0 SHEET 2 AA7 4 THR G 105 VAL G 109 1 O THR G 108 N GLY G 12 SHEET 3 AA7 4 ASP G 86 ASP G 93 -1 N TYR G 87 O THR G 105 SHEET 4 AA7 4 ALA G 98 PHE G 101 -1 O ALA G 98 N ASP G 93 SHEET 1 AA8 3 ILE G 20 SER G 23 0 SHEET 2 AA8 3 SER G 71 GLY G 75 -1 O LEU G 74 N ILE G 20 SHEET 3 AA8 3 SER G 64 SER G 68 -1 N SER G 68 O SER G 71 SHEET 1 AA9 2 GLN N 3 LEU N 4 0 SHEET 2 AA9 2 VAL N 25 SER N 26 -1 O SER N 26 N GLN N 3 SHEET 1 AB1 3 SER N 22 CYS N 23 0 SHEET 2 AB1 3 THR N 79 LEU N 84 -1 O ALA N 80 N CYS N 23 SHEET 3 AB1 3 VAL N 69 ASP N 74 -1 N THR N 70 O GLU N 83 SHEET 1 AB2 3 LEU N 46 MET N 49 0 SHEET 2 AB2 3 ALA N 34 GLN N 40 -1 N ARG N 39 O GLU N 47 SHEET 3 AB2 3 VAL N 94 THR N 100 -1 O VAL N 94 N GLN N 40 SSBOND 1 CYS B 15 CYS B 136 1555 1555 2.03 SSBOND 2 CYS B 131 CYS B 166 1555 1555 2.02 SSBOND 3 CYS G 22 CYS G 89 1555 1555 2.03 SSBOND 4 CYS N 23 CYS N 97 1555 1555 2.04 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000